anti-GZMM antibody product blog
Tags: Antibody; Monoclonal Antibody; anti-Gzmm antibody; Gzmm; Granzyme M (GZMM);
The GZMM gzmm (Catalog #MBS2090606) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Monoclonal Antibody to Granzyme M (GZMM) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Granzyme M (GZMM) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).Western Blot: 0.5-5ug/mL
Immunohistochemistry: 5-30ug/mL
Immunocytochemistry: 5-30ug/mL. Researchers should empirically determine the suitability of the GZMM gzmm for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The GZMM gzmm product has the following accession number(s) (GI #385275110) (NCBI Accession #NP_001245280.1) (Uniprot Accession #P51124). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Monoclonal Antibody to Granzyme M (GZMM) with the following immunoassay(s):
Western Blot (WB) (Western Blot: Sample: Recombinant GZMM, Human.)
Immunogen: Recombinant Granzyme M (GZMM)
Cross Reactivity: Human. Buffer Formulation: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing GZMM are readily searchable from our website. Different antibodies against the same target such as GZMM may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Atherosclerosis, Hemorrhage, Immune System Diseases, Inflammation are some of the diseases may be linked to Monoclonal Antibody to Granzyme M (GZMM). The following patways have been known to be associated with this gene.